Kinetin Inhibits Proliferation of Hepatic Stellate Cells by Interrupting Cell Cycle and Induces Apoptosis by Down-regulating Ratio of Bcl-2/Bax

Liver fibrosis is an important health problem that can further progress into cirrhosis or liver cancer,and result in significant morbidity and mortality. Inhibiting proliferation and inducing apoptosis of hepatic stellate cells(HSCs) may be the key point to reverse liver fibrosis. At present,anti-fi...

Full description

Saved in:
Bibliographic Details
Published inJournal of Huazhong University of Science and Technology. Medical sciences Vol. 35; no. 5; pp. 672 - 678
Main Author 张振纲 邹婕 黄莹 吴亮
Format Journal Article
LanguageEnglish
Published Wuhan Huazhong University of Science and Technology 01.10.2015
Department of Infectious Diseases, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology,Wuhan 430030, China%Wuhan Institute of Skin Disease Prevention and Control, Wuhan 430030, China
Subjects
Online AccessGet full text
ISSN1672-0733
1993-1352
DOI10.1007/s11596-015-1488-0

Cover

Abstract Liver fibrosis is an important health problem that can further progress into cirrhosis or liver cancer,and result in significant morbidity and mortality. Inhibiting proliferation and inducing apoptosis of hepatic stellate cells(HSCs) may be the key point to reverse liver fibrosis. At present,anti-fibrosis drugs are rare. Kinetin is a type of plant-derived cytokinin which has been reported to control differentiation and induce apoptosis of human cells. In this study,the HSCs were incubated with different concentrations of kinetin. The proliferation of rat HSCs was measured by MTT assay,cell cycle and apoptosis were analyzed by flow cytometry,and the apoptosis was examined by TUNEL method. The expression of Bcl-2 and Bax proteins was detected by immunocytochemistry staining. It was found that kinetin could markedly inhibit proliferation of HSCs. In a concentration range of 2 to 8 μg/m L,the inhibitory effects of kinetin on proliferation of HSCs were increased with the increased concentration and the extension of time(P〈0.01). Flow cytometry indicated that kinetin could inhibit the DNA synthesis from G0/G1 to S phase in a dose-dependent manner(P〈0.01). The apoptosis rates of the HSCs treated with 8,4 and 2 μg/m L kinetin(25.62%±2.21%,15.31%±1.9% and 6.18%±1.23%,respectively) were increased significantly compared with the control group(3.81%±0.93%)(P〈0.01). All the DNA frequency histogram in kinetin-treated groups showed obvious hypodiploid peak(sub-G1 peak),and with the increase of kinetin concentrations,the apoptosis rate of HSCs also showed a trend of increase. It was also found that kinetin could down-regulate the expression of Bcl-2,and up-regulate the expression of Bax,leading to the decreased ratio of Bcl-2/Bax significantly. The kinetin-induced apoptosis of HSCs was positively correlated with the expression of Bax,and negatively with the expression of Bcl-2. It was concluded that kinetin can inhibit activation and proliferation of HSCs by interrupting the cell cycle at G1/S restriction point and inducing apoptosis of HSCs via reducing the ratio of Bcl-2/Bax.
AbstractList Liver fibrosis is an important health problem that can further progress into cirrhosis or liver cancer, and result in significant morbidity and mortality. Inhibiting proliferation and inducing apoptosis of hepatic stellate cells (HSCs) may be the key point to reverse liver fibrosis. At present, anti-fibrosis drugs are rare. Kinetin is a type of plant-derived cytokinin which has been reported to control differentiation and induce apoptosis of human cells. In this study, the HSCs were incubated with different concentrations of kinetin. The proliferation of rat HSCs was measured by MTT assay, cell cycle and apoptosis were analyzed by flow cytometry, and the apoptosis was examined by TUNEL method. The expression of Bcl-2 and Bax proteins was detected by immunocytochemistry staining. It was found that kinetin could markedly inhibit proliferation of HSCs. In a concentration range of 2 to 8 μg/mL, the inhibitory effects of kinetin on proliferation of HSCs were increased with the increased concentration and the extension of time (P < 0.01). Flow cytometry indicated that kinetin could inhibit the DNA synthesis from G0/G1 to S phase in a dose-dependent manner (P < 0.01). The apoptosis rates of the HSCs treated with 8, 4 and 2 μg/mL kinetin (25.62% ± 2.21%, 15.31% ± 1.9% and 6.18% ± 1.23%, respectively) were increased significantly compared with the control group (3.81% ± 0.93%) (P < 0.01). All the DNA frequency histogram in kinetin-treated groups showed obvious hypodiploid peak (sub-G1 peak), and with the increase of kinetin concentrations, the apoptosis rate of HSCs also showed a trend of increase. It was also found that kinetin could down-regulate the expression of Bcl-2, and up-regulate the expression of Bax, leading to the decreased ratio of Bcl-2/Bax significantly. The kinetin-induced apoptosis of HSCs was positively correlated with the expression of Bax, and negatively with the expression of Bcl-2. It was concluded that kinetin can inhibit activation and proliferation of HSCs by interrupting the cell cycle at G1/S restriction point and inducing apoptosis of HSCs via reducing the ratio of Bcl-2/Bax.
Summary Liver fibrosis is an important health problem that can further progress into cirrhosis or liver cancer, and result in significant morbidity and mortality. Inhibiting proliferation and inducing apoptosis of hepatic stellate cells (HSCs) may be the key point to reverse liver fibrosis. At present, anti-fibrosis drugs are rare. Kinetin is a type of plant-derived cytokinin which has been reported to control differentiation and induce apoptosis of human cells. In this study, the HSCs were incubated with different concentrations of kinetin. The proliferation of rat HSCs was measured by MTT assay, cell cycle and apoptosis were analyzed by flow cytometry, and the apoptosis was examined by TUNEL method. The expression of Bcl-2 and Bax proteins was detected by immunocytochemistry staining. It was found that kinetin could markedly inhibit proliferation of HSCs. In a concentration range of 2 to 8 μg/mL, the inhibitory effects of kinetin on proliferation of HSCs were increased with the increased concentration and the extension of time ( P <0.01). Flow cytometry indicated that kinetin could inhibit the DNA synthesis from G0/G1 to S phase in a dose-dependent manner ( P <0.01). The apoptosis rates of the HSCs treated with 8, 4 and 2 μg/mL kinetin (25.62%±2.21%, 15.31%±1.9% and 6.18%±1.23%, respectively) were increased significantly compared with the control group (3.81%±0.93%) ( P <0.01). All the DNA frequency histogram in kinetin-treated groups showed obvious hypodiploid peak (sub-G1 peak), and with the increase of kinetin concentrations, the apoptosis rate of HSCs also showed a trend of increase. It was also found that kinetin could down-regulate the expression of Bcl-2, and up-regulate the expression of Bax, leading to the decreased ratio of Bcl-2/Bax significantly. The kinetin-induced apoptosis of HSCs was positively correlated with the expression of Bax, and negatively with the expression of Bcl-2. It was concluded that kinetin can inhibit activation and proliferation of HSCs by interrupting the cell cycle at G1/S restriction point and inducing apoptosis of HSCs via reducing the ratio of Bcl-2/Bax.
Liver fibrosis is an important health problem that can further progress into cirrhosis or liver cancer,and result in significant morbidity and mortality. Inhibiting proliferation and inducing apoptosis of hepatic stellate cells(HSCs) may be the key point to reverse liver fibrosis. At present,anti-fibrosis drugs are rare. Kinetin is a type of plant-derived cytokinin which has been reported to control differentiation and induce apoptosis of human cells. In this study,the HSCs were incubated with different concentrations of kinetin. The proliferation of rat HSCs was measured by MTT assay,cell cycle and apoptosis were analyzed by flow cytometry,and the apoptosis was examined by TUNEL method. The expression of Bcl-2 and Bax proteins was detected by immunocytochemistry staining. It was found that kinetin could markedly inhibit proliferation of HSCs. In a concentration range of 2 to 8 μg/m L,the inhibitory effects of kinetin on proliferation of HSCs were increased with the increased concentration and the extension of time(P〈0.01). Flow cytometry indicated that kinetin could inhibit the DNA synthesis from G0/G1 to S phase in a dose-dependent manner(P〈0.01). The apoptosis rates of the HSCs treated with 8,4 and 2 μg/m L kinetin(25.62%±2.21%,15.31%±1.9% and 6.18%±1.23%,respectively) were increased significantly compared with the control group(3.81%±0.93%)(P〈0.01). All the DNA frequency histogram in kinetin-treated groups showed obvious hypodiploid peak(sub-G1 peak),and with the increase of kinetin concentrations,the apoptosis rate of HSCs also showed a trend of increase. It was also found that kinetin could down-regulate the expression of Bcl-2,and up-regulate the expression of Bax,leading to the decreased ratio of Bcl-2/Bax significantly. The kinetin-induced apoptosis of HSCs was positively correlated with the expression of Bax,and negatively with the expression of Bcl-2. It was concluded that kinetin can inhibit activation and proliferation of HSCs by interrupting the cell cycle at G1/S restriction point and inducing apoptosis of HSCs via reducing the ratio of Bcl-2/Bax.
Author 张振纲 邹婕 黄莹 吴亮
AuthorAffiliation Department of Infectious Diseases, Tongji Hospital Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China Wuhan Institute of Skin Disease Prevention and Control Wuhan 430030, China
AuthorAffiliation_xml – name: Department of Infectious Diseases, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology,Wuhan 430030, China%Wuhan Institute of Skin Disease Prevention and Control, Wuhan 430030, China
Author_xml – sequence: 1
  fullname: 张振纲 邹婕 黄莹 吴亮
BackLink https://www.ncbi.nlm.nih.gov/pubmed/26489620$$D View this record in MEDLINE/PubMed
BookMark eNp9kU1v1DAQhi1URD_gB3BBFldkOk5iJzm2C7QVlUB8nC3bcVIvqR1sr7r7K_jLdTalSBx6mpHnfeYdzxyjA-edQeg1hfcUoD6NlLKWE6CM0KppCDxDR7RtS0JLVhzknNcFgbosD9FxjGsAVvOieoEOC141LS_gCP35bJ1J1uErd2OVTRF_DX60vQkyWe-w7_GlmXKu8fdkxlEmg1c5Rqx2mUkmhM2U-WH_ilc7PRosXZdr3UabiM8mPyUf7R744O8cCWbY5D4z8202mT3O9UiK03O5fYme93KM5tVDPEE_P338sbok118urlZn10RXUCeioaOmYWC4hvxJWdBOK8lNA1JDU1VMtY1qNQdVlqxrW9q0tFes6iivlNZdeYLeLX3vpOulG8Tab4LLjiKtd7-67VYJU-TFAgMKWf1mUU8bdWs6MQV7K8NO_N1jFtBFoIOPMZj-UUJBzLcSy61EbinmW4mZqf9jtE37racg7fgkWSxkzC5uMOHf9E9Bbx_sbrwbfmfucUbOeUlrzpryHplwtGk
CitedBy_id crossref_primary_10_1007_s11596_017_1699_7
crossref_primary_10_3390_nu14071495
crossref_primary_10_1016_j_fbio_2023_103454
crossref_primary_10_1007_s12032_020_1338_1
crossref_primary_10_1016_j_taap_2023_116655
crossref_primary_10_1155_2018_2768120
Cites_doi 10.1016/j.bpg.2011.02.005
10.1152/ajpgi.00451.2010
10.1007/978-1-60327-409-8_1
10.1104/pp.104.900160
10.1016/j.biopha.2012.10.002
10.1016/j.jhep.2011.09.024
10.1016/j.cld.2008.07.011
10.1186/1472-6882-14-449
10.1016/j.cgh.2013.01.005
10.1186/1471-2407-10-238
10.2741/reeves
10.1053/j.gastro.2008.03.003
10.1152/physrev.00013.2007
10.1172/JCI24282
10.1093/hmg/ddh046
10.1016/j.cbi.2011.07.001
10.1055/s-2008-1040454
10.1046/j.1365-2184.2003.00266.x
10.1136/gutjnl-2014-306842
10.1172/JCI1018
10.1016/S0925-4439(97)00028-8
10.1016/S0168-8278(02)00429-4
10.1159/000201257
10.1016/S0014-2999(03)01528-0
10.1007/s00204-014-1448-7
10.1111/jgh.1998.13.s1.33
10.1016/S0021-9258(18)81686-6
10.3892/mmr.2012.1076
ContentType Journal Article
Copyright Huazhong University of Science and Technology and Springer-Verlag Berlin Heidelberg 2015
Copyright © Wanfang Data Co. Ltd. All Rights Reserved.
Copyright_xml – notice: Huazhong University of Science and Technology and Springer-Verlag Berlin Heidelberg 2015
– notice: Copyright © Wanfang Data Co. Ltd. All Rights Reserved.
DBID 2RA
92L
CQIGP
W91
~WA
AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
2B.
4A8
92I
93N
PSX
TCJ
DOI 10.1007/s11596-015-1488-0
DatabaseName 中文科技期刊数据库
中文科技期刊数据库-CALIS站点
中文科技期刊数据库-7.0平台
中文科技期刊数据库-医药卫生
中文科技期刊数据库- 镜像站点
CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
Wanfang Data Journals - Hong Kong
WANFANG Data Centre
Wanfang Data Journals
万方数据期刊 - 香港版
China Online Journals (COJ)
China Online Journals (COJ)
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
DatabaseTitleList MEDLINE


Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
DocumentTitleAlternate Kinetin Inhibits Proliferation of Hepatic Stellate Cells by Interrupting Cell Cycle and Induces Apoptosis by Down-regulating Ratio of Bcl-2/Bax
EISSN 1993-1352
EndPage 678
ExternalDocumentID tjykdxxb_e201505010
26489620
10_1007_s11596_015_1488_0
666317658
Genre Research Support, Non-U.S. Gov't
Journal Article
GrantInformation_xml – fundername: This study was supported by a grant from Hubei Natural Science Foundation of China
  funderid: (2013CFB135)
GroupedDBID -5E
-5G
-BR
-Y2
-~C
.86
.VR
06C
06D
0R~
0VY
1N0
29K
29~
2B.
2C~
2J2
2KG
2KM
2LR
2RA
2~H
30V
4.4
408
40D
40E
53G
5GY
5VS
6NX
8TC
8UJ
92F
92I
92L
95-
95.
95~
96X
AAAVM
AABHQ
AAJKR
AANXM
AARHV
AARTL
AAYIU
AAYQN
AAYTO
ABFTV
ABJNI
ABJOX
ABKCH
ABMNI
ABNWP
ABQBU
ABTMW
ACGFS
ACHXU
ACKNC
ACOMO
ACSNA
ACUDM
ADHIR
ADINQ
ADKPE
ADURQ
ADYFF
ADZKW
AEBTG
AEGNC
AEJHL
AEKMD
AEOHA
AEPYU
AETLH
AEXYK
AFWTZ
AFZKB
AGAYW
AGDGC
AGQMX
AGWIL
AGWZB
AGYKE
AHAVH
AHBYD
AHKAY
AHYZX
AIIXL
AJBLW
AJRNO
ALMA_UNASSIGNED_HOLDINGS
ALWAN
AMKLP
ARMRJ
AZFZN
B-.
BA0
BGNMA
CAG
CCEZO
CHBEP
CIEJG
COF
CQIGP
CS3
CSCUP
CW9
D-I
DPUIP
EBS
EJD
ESBYG
FA0
FEDTE
FNLPD
FRRFC
FWDCC
G-Y
G-Z
GGCAI
GGRSB
GJIRD
GQ6
GQ7
HF~
HG6
HMJXF
HRMNR
HVGLF
HZ~
IJ-
IXD
I~X
I~Z
J-C
JBSCW
JUIAU
KOV
M4Y
MA-
N2Q
NDZJH
NQJWS
NU0
O9-
O93
O9I
O9J
P9S
PF0
QOR
QOS
R-E
R89
R9I
RIG
ROL
RPX
RSV
S..
S16
S1Z
S27
S37
S3B
SAP
SCL
SDH
SHX
SMD
SNE
SNX
SOJ
SPISZ
SZ9
SZN
T13
TCJ
TSG
TT1
TUC
U2A
U9L
UG4
VC2
W48
W91
WK8
Z7U
Z82
Z8V
ZOVNA
~A9
~WA
ABQSL
H13
AAYXX
ADHKG
AGQPQ
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
4A8
93N
PSX
ID FETCH-LOGICAL-c407t-c0d1e850e6c0672a21dcba6e80ac08445b98b9c60b335d991891fb54d164bccd3
IEDL.DBID AGYKE
ISSN 1672-0733
IngestDate Thu May 29 04:06:47 EDT 2025
Thu Apr 03 06:58:39 EDT 2025
Tue Jul 01 00:21:58 EDT 2025
Thu Apr 24 23:01:22 EDT 2025
Fri Feb 21 02:37:17 EST 2025
Wed Feb 14 10:28:39 EST 2024
IsPeerReviewed false
IsScholarly false
Issue 5
Keywords kinetin
apoptosis
liver fibrosis
hepatic stellate cell
proliferation
Language English
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c407t-c0d1e850e6c0672a21dcba6e80ac08445b98b9c60b335d991891fb54d164bccd3
Notes Apoptosis cytometry regulating inhibit inducing cirrhosis markedly stellate manner regulate
Liver fibrosis is an important health problem that can further progress into cirrhosis or liver cancer,and result in significant morbidity and mortality. Inhibiting proliferation and inducing apoptosis of hepatic stellate cells(HSCs) may be the key point to reverse liver fibrosis. At present,anti-fibrosis drugs are rare. Kinetin is a type of plant-derived cytokinin which has been reported to control differentiation and induce apoptosis of human cells. In this study,the HSCs were incubated with different concentrations of kinetin. The proliferation of rat HSCs was measured by MTT assay,cell cycle and apoptosis were analyzed by flow cytometry,and the apoptosis was examined by TUNEL method. The expression of Bcl-2 and Bax proteins was detected by immunocytochemistry staining. It was found that kinetin could markedly inhibit proliferation of HSCs. In a concentration range of 2 to 8 μg/m L,the inhibitory effects of kinetin on proliferation of HSCs were increased with the increased concentration and the extension of time(P〈0.01). Flow cytometry indicated that kinetin could inhibit the DNA synthesis from G0/G1 to S phase in a dose-dependent manner(P〈0.01). The apoptosis rates of the HSCs treated with 8,4 and 2 μg/m L kinetin(25.62%±2.21%,15.31%±1.9% and 6.18%±1.23%,respectively) were increased significantly compared with the control group(3.81%±0.93%)(P〈0.01). All the DNA frequency histogram in kinetin-treated groups showed obvious hypodiploid peak(sub-G1 peak),and with the increase of kinetin concentrations,the apoptosis rate of HSCs also showed a trend of increase. It was also found that kinetin could down-regulate the expression of Bcl-2,and up-regulate the expression of Bax,leading to the decreased ratio of Bcl-2/Bax significantly. The kinetin-induced apoptosis of HSCs was positively correlated with the expression of Bax,and negatively with the expression of Bcl-2. It was concluded that kinetin can inhibit activation and proliferation of HSCs by interrupting the cell cycle at G1/S restriction point and inducing apoptosis of HSCs via reducing the ratio of Bcl-2/Bax.
Zhen-gang ZHANG, Jie ZOU,Ying HUANG , Liang WU (1Department of Infectious Diseases, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China 2Wuhan Institute of Skin Disease Prevention and Control, Wuhan 430030, China)
42-1679/R
PMID 26489620
PageCount 7
ParticipantIDs wanfang_journals_tjykdxxb_e201505010
pubmed_primary_26489620
crossref_primary_10_1007_s11596_015_1488_0
crossref_citationtrail_10_1007_s11596_015_1488_0
springer_journals_10_1007_s11596_015_1488_0
chongqing_primary_666317658
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2015-10-01
PublicationDateYYYYMMDD 2015-10-01
PublicationDate_xml – month: 10
  year: 2015
  text: 2015-10-01
  day: 01
PublicationDecade 2010
PublicationPlace Wuhan
PublicationPlace_xml – name: Wuhan
– name: China
PublicationSubtitle Medical Sciences
PublicationTitle Journal of Huazhong University of Science and Technology. Medical sciences
PublicationTitleAbbrev J. Huazhong Univ. Sci. Technol. [Med. Sci.]
PublicationTitleAlternate Journal of Zuazhong University of Science and Technology: Medical Edition
PublicationTitle_FL Journal of Huazhong University of Science and Technology(Medical Science)
PublicationYear 2015
Publisher Huazhong University of Science and Technology
Department of Infectious Diseases, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology,Wuhan 430030, China%Wuhan Institute of Skin Disease Prevention and Control, Wuhan 430030, China
Publisher_xml – name: Huazhong University of Science and Technology
– name: Department of Infectious Diseases, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology,Wuhan 430030, China%Wuhan Institute of Skin Disease Prevention and Control, Wuhan 430030, China
References Greenwel, Rojkind (CR24) 1997; 1361
Geng, Wang, Sun (CR30) 2015
Siddiqui, Ahad, Ahsan (CR35) 2015; 89
Slaugenhaupt, Mull, Leyne (CR20) 2004; 13
Hsiao, Shen, Lin (CR19) 2003; 465
Mormone, George, Nieto (CR1) 2011; 193
Bataller, Brenner (CR2) 2005; 115
Friedman (CR26) 1990; 10
Kong, Zhang, Zhang (CR34) 2013; 67
Ellis, Mann (CR9) 2012; 56
Iredale, Benyon, Pichering (CR25) 1998; 102
Loo (CR33) 2011; 682
Friedman (CR5) 2008; 88
Kowalska (CR18) 1992; 51
Lee, Wallace, Friedman (CR14) 2015; 64
Rockey (CR10) 2013; 11
Ishii, Hori, Sakai (CR21) 2002; 13
Reeves, Friedman (CR3) 2002; 7
Zhang, Tian, Zhou (CR22) 2006; 14
Vermeulen, Van Bockstaele, Berneman (CR32) 2003; 36
Amasino (CR17) 2005; 138
Lee, Friedman (CR6) 2011; 25
Friedman, Roll, Boyles (CR28) 1989; 264
Gressner, Bachem (CR27) 1995; 56
Fang, Li, An (CR12) 2011; 27
Friedman (CR15) 2003; 38
Tao, Yan, Zhou (CR29) 2014; 18
Fallowfield (CR16) 2011; 300
(CR8) 2002; 4
Liu, Wei, Huo (CR13) 2012; 6
Friedman (CR4) 2008; 134
Vanamala, Reddivari, Radhakrishnan (CR31) 2010; 10
Arthur, Mann, Iredale (CR23) 1998; 13
(CR7) 2009; 25
Rockey (CR11) 2008; 12
Y Ishii (1488_CR21) 2002; 13
K Vermeulen (1488_CR32) 2003; 36
DT Loo (1488_CR33) 2011; 682
J Vanamala (1488_CR31) 2010; 10
JA Fallowfield (1488_CR16) 2011; 300
R Amasino (1488_CR17) 2005; 138
D Kong (1488_CR34) 2013; 67
SL Friedman (1488_CR4) 2008; 134
SL Friedman (1488_CR28) 1989; 264
YY Tao (1488_CR29) 2014; 18
WA Siddiqui (1488_CR35) 2015; 89
AM Gressner (1488_CR27) 1995; 56
R Bataller (1488_CR2) 2005; 115
SA Slaugenhaupt (1488_CR20) 2004; 13
(1488_CR8) 2002; 4
L Liu (1488_CR13) 2012; 6
G Hsiao (1488_CR19) 2003; 465
DC Rockey (1488_CR11) 2008; 12
E Kowalska (1488_CR18) 1992; 51
YA Lee (1488_CR14) 2015; 64
SL Friedman (1488_CR26) 1990; 10
HL Reeves (1488_CR3) 2002; 7
MJ Arthur (1488_CR23) 1998; 13
ZG Zhang (1488_CR22) 2006; 14
Y Geng (1488_CR30) 2015
UE Lee (1488_CR6) 2011; 25
(1488_CR7) 2009; 25
EL Ellis (1488_CR9) 2012; 56
SL Friedman (1488_CR15) 2003; 38
JP Iredale (1488_CR25) 1998; 102
SM Fang (1488_CR12) 2011; 27
DC Rockey (1488_CR10) 2013; 11
E Mormone (1488_CR1) 2011; 193
SL Friedman (1488_CR5) 2008; 88
P Greenwel (1488_CR24) 1997; 1361
17064479 - Zhonghua Gan Zang Bing Za Zhi. 2006 Oct;14(10):780-2
2732246 - J Biol Chem. 1989 Jun 25;264(18):10756-62
12681440 - Eur J Pharmacol. 2003 Apr 4;465(3):281-7
11801528 - Cell Growth Differ. 2002 Jan;13(1):19-26
12814430 - Cell Prolif. 2003 Jun;36(3):131-49
20504360 - BMC Cancer. 2010 May 26;10 :238
2186486 - Semin Liver Dis. 1990 Feb;10(1):20-9
15690074 - J Clin Invest. 2005 Feb;115(2):209-18
11897564 - Front Biosci. 2002 Apr 01;7:d808-26
23201010 - Biomed Pharmacother. 2013 Apr;67(3):246-50
25753357 - Hepatol Res. 2016 Mar;46(3):E15-25
23305825 - Clin Gastroenterol Hepatol. 2013 Mar;11(3):224-31.e1-5
21803030 - Chem Biol Interact. 2011 Sep 30;193(3):225-31
22245903 - J Hepatol. 2012 May;56(5):1171-80
22295510 - Zhongguo Ying Yong Sheng Li Xue Za Zhi. 2011 Nov;27(4):402-6
25407538 - BMC Complement Altern Med. 2014 Nov 18;14 :449
9300799 - Biochim Biophys Acta. 1997 Aug 22;1361(2):177-84
21057916 - Methods Mol Biol. 2011;682:3-13
25681399 - Gut. 2015 May;64(5):830-41
25618543 - Arch Toxicol. 2015 Mar;89(3):289-317
16009993 - Plant Physiol. 2005 Jul;138(3):1177-84
9691091 - J Clin Invest. 1998 Aug 1;102(3):538-49
21497738 - Best Pract Res Clin Gastroenterol. 2011 Apr;25(2):195-206
28976699 - J Gastroenterol Hepatol. 1998 Sep;13(S1):S33-S38
8549875 - Digestion. 1995;56(5):335-46
18471545 - Gastroenterology. 2008 May;134(6):1655-69
22971838 - Mol Med Rep. 2012 Dec;6(6):1231-8
12591185 - J Hepatol. 2003;38 Suppl 1:S38-53
18984475 - Clin Liver Dis. 2008 Nov;12(4):939-62, xi
1478568 - Folia Morphol (Warsz). 1992;51(2):109-18
21233278 - Am J Physiol Gastrointest Liver Physiol. 2011 May;300(5):G709-15
14709595 - Hum Mol Genet. 2004 Feb 15;13(4):429-36
18195085 - Physiol Rev. 2008 Jan;88(1):125-72
References_xml – volume: 264
  start-page: 10756
  issue: 18
  year: 1989
  end-page: 10762
  ident: CR28
  article-title: Maintenance of differentiated phenotype of cultured rat hepatic lipocytes by basement membrane matrix
  publication-title: J Biol Chem
– volume: 25
  start-page: 195
  issue: 2
  year: 2011
  end-page: 206
  ident: CR6
  article-title: Mechanisms of hepatic fibrogenesis
  publication-title: Best Pract Res Clin Gastroenterol
  doi: 10.1016/j.bpg.2011.02.005
– volume: 300
  start-page: G709
  issue: 5
  year: 2011
  end-page: G715
  ident: CR16
  article-title: Therapeutic targets in liver fibrosis
  publication-title: Am J Physiol Gastrointest Liver Physiol
  doi: 10.1152/ajpgi.00451.2010
– volume: 13
  start-page: S33
  year: 1998
  end-page: S38
  ident: CR23
  article-title: Tissue inhibitors of metalloproteinases, hepatic stellate cells and liver fibrosis
  publication-title: J Gastroenterol Hepatol
– volume: 682
  start-page: 3
  year: 2011
  end-page: 13
  ident: CR33
  article-title: In situ detection of apoptosis by the TUNEL assay: an overview of techniques
  publication-title: Methods Mol Biol
  doi: 10.1007/978-1-60327-409-8_1
– volume: 13
  start-page: 19
  issue: 1
  year: 2002
  end-page: 26
  ident: CR21
  article-title: Control of differentiation and apoptosis of human myeloid leukemia cell by cytokinins and cytokinin nucleosides, plant redifferentiatian—inducing hormones
  publication-title: Cell Growth Differ
– volume: 138
  start-page: 1177
  issue: 3
  year: 2005
  end-page: 1184
  ident: CR17
  article-title: 1955: Kinetin Arrives. The 50th Anniversary of a New Plant Hormone
  publication-title: Plant Physiol
  doi: 10.1104/pp.104.900160
– volume: 67
  start-page: 246
  issue: 3
  year: 2013
  end-page: 250
  ident: CR34
  article-title: Clearance of activated stellate cells for hepatic fibrosis regression: molecular basis and translational potential
  publication-title: Biomed Pharmacother
  doi: 10.1016/j.biopha.2012.10.002
– volume: 56
  start-page: 1171
  issue: 5
  year: 2012
  end-page: 1180
  ident: CR9
  article-title: Clinical evidence for the regression of liver fibrosis
  publication-title: J Hepatol
  doi: 10.1016/j.jhep.2011.09.024
– volume: 6
  start-page: 1231
  issue: 6
  year: 2012
  end-page: 1238
  ident: CR13
  article-title: The Salvia miltiorrhiza monomer IH764–3 induces apoptosis of hepatic stellate cells in vivo in a bile duct ligation-induced model of liver fibrosis
  publication-title: Mol Med Rep
– year: 2015
  ident: CR30
  article-title: Identification of Antrodin B from Antrodia camphorata as a new anti-hepatofibrotic compound using a rapid cell screening method and biological evaluation
  publication-title: Hepatol Res
– volume: 25
  issue: 3
  year: 2009
  ident: CR7
  publication-title: Curr Opin Gastroenterol
– volume: 12
  start-page: 939
  issue: 4
  year: 2008
  end-page: 962
  ident: CR11
  article-title: Current and future anti-fibrotic therapies for chronic liver disease
  publication-title: Clin Liver Dis
  doi: 10.1016/j.cld.2008.07.011
– volume: 18
  start-page: 449
  issue: 11
  year: 2014
  end-page: 462
  ident: CR29
  article-title: Fuzheng Huayu recipe alleviates hepatic fibrosis via inhibiting TNF-α induced hepatocyte apoptosis
  publication-title: BMC Complement Altern Med
  doi: 10.1186/1472-6882-14-449
– volume: 11
  start-page: 224
  issue: 3
  year: 2013
  end-page: 231
  ident: CR10
  article-title: Translating and understanding of the pathogenesis of hepatic fibrosis to novel therapies
  publication-title: Clin Gastroenterol Hepatol
  doi: 10.1016/j.cgh.2013.01.005
– volume: 10
  start-page: 238
  year: 2010
  end-page: 252
  ident: CR31
  article-title: Resveratrol suppresses IGF-1 induced human colon cancer cell proliferation and elevates apoptosis via suppression of IGF-1R/Wnt and activation of p53 signaling pathways
  publication-title: BMC Cancer
  doi: 10.1186/1471-2407-10-238
– volume: 7
  start-page: d808
  issue: 4
  year: 2002
  end-page: d826
  ident: CR3
  article-title: Activation of hepatic stellate cells—a key issue in liver fibrosis
  publication-title: Front Biosci
  doi: 10.2741/reeves
– volume: 134
  start-page: 1655
  issue: 6
  year: 2008
  end-page: 1669
  ident: CR4
  article-title: Mechanisms of hepatic fibrogenesis
  publication-title: Gastroenterology
  doi: 10.1053/j.gastro.2008.03.003
– volume: 88
  start-page: 125
  issue: 1
  year: 2008
  end-page: 172
  ident: CR5
  article-title: Hepatic stellate cells: protean, multifunctional and enigmatic cells of the liver
  publication-title: Physiol Rev
  doi: 10.1152/physrev.00013.2007
– volume: 115
  start-page: 209
  issue: 2
  year: 2005
  end-page: 218
  ident: CR2
  article-title: Liver fibrosis
  publication-title: J Clin Invest
  doi: 10.1172/JCI24282
– volume: 13
  start-page: 429
  issue: 4
  year: 2004
  end-page: 436
  ident: CR20
  article-title: Rescue of a human mRNA splicing defect by the plant cytokinin kinetin
  publication-title: Hum Mol Genet
  doi: 10.1093/hmg/ddh046
– volume: 51
  start-page: 109
  issue: 2
  year: 1992
  end-page: 118
  ident: CR18
  article-title: Influence of kinetin (6-furfurylo-aminopurine) on human fibroblasts in the cell culture
  publication-title: Folia Morphol (Warsz)
– volume: 193
  start-page: 225
  issue: 3
  year: 2011
  end-page: 231
  ident: CR1
  article-title: Molecular pathogenesis of hepatic fibrosis and current therapeutic approaches
  publication-title: Chem Biol Interaction
  doi: 10.1016/j.cbi.2011.07.001
– volume: 10
  start-page: 20
  issue: 1
  year: 1990
  end-page: 29
  ident: CR26
  article-title: Cellular sources of collagen and regulation of collagen production in liver
  publication-title: Semin Liver Dis
  doi: 10.1055/s-2008-1040454
– volume: 36
  start-page: 131
  issue: 3
  year: 2003
  end-page: 149
  ident: CR32
  article-title: The cell cycle: a review of regulation, deregulation and therapeutic targets in cancer
  publication-title: Cell Prolif
  doi: 10.1046/j.1365-2184.2003.00266.x
– volume: 27
  start-page: 402
  issue: 4
  year: 2011
  end-page: 406
  ident: CR12
  article-title: The role of extracellular signal-regulated kinase in induction of apoptosis with salvia miltiorrhiza monomer IH764–3 in hepatic stellate cells
  publication-title: Zhongguo Ying Yong Sheng Li Xue Za Zhi (Chinese)
– volume: 64
  start-page: 830
  issue: 5
  year: 2015
  end-page: 841
  ident: CR14
  article-title: Pathobiology of liver fibrosis: a translational success story
  publication-title: Gut
  doi: 10.1136/gutjnl-2014-306842
– volume: 102
  start-page: 538
  issue: 3
  year: 1998
  end-page: 549
  ident: CR25
  article-title: Meclianisms of spontaneous resolution of rat liver fibrosis
  publication-title: Clin Invest
  doi: 10.1172/JCI1018
– volume: 1361
  start-page: 177
  issue: 2
  year: 1997
  end-page: 184
  ident: CR24
  article-title: Accelerated development of liver fibrosis in CCl4 —treated rats by the weekly induction of acute phase response episodes:upregulation of alpha1(I) procollagen and tissue inhibitor of metalloproteinase-1 mRNAs
  publication-title: Biochim Biophys Acta
  doi: 10.1016/S0925-4439(97)00028-8
– volume: 38
  start-page: S38
  issue: 1
  year: 2003
  end-page: S53
  ident: CR15
  article-title: Liver fibrosis-from bench to bedside
  publication-title: J Hepatol
  doi: 10.1016/S0168-8278(02)00429-4
– volume: 56
  start-page: 335
  issue: 5
  year: 1995
  end-page: 346
  ident: CR27
  article-title: Molecular mechanisms of liver fibrogenesis—a homage to the role of activated fat— storing cells
  publication-title: Digestion
  doi: 10.1159/000201257
– volume: 14
  start-page: 780
  issue: 10
  year: 2006
  end-page: 782
  ident: CR22
  article-title: Effect of kinetin on expression of collagen type I, III, IV and transforming growth factor beta-1 in livers of rats with hepatic fibrosis
  publication-title: Zhonghua Gan Zang Bing Za Zhi (Chinese)
– volume: 465
  start-page: 281
  issue: 3
  year: 2003
  end-page: 287
  ident: CR19
  article-title: Inhibitory activity of kinetin on free radical formation of activated platelets in vitro and on thrombus formation in vivo
  publication-title: Eur J Pharmacol
  doi: 10.1016/S0014-2999(03)01528-0
– volume: 89
  start-page: 289
  issue: 3
  year: 2015
  end-page: 317
  ident: CR35
  article-title: The mystery of BCL2 family: Bcl-2 proteins and apoptosis: an update
  publication-title: Arch Toxicol
  doi: 10.1007/s00204-014-1448-7
– volume: 4
  issue: 3
  year: 2002
  ident: CR8
  publication-title: Med Gen Med
– volume: 7
  start-page: d808
  issue: 4
  year: 2002
  ident: 1488_CR3
  publication-title: Front Biosci
  doi: 10.2741/reeves
– volume: 1361
  start-page: 177
  issue: 2
  year: 1997
  ident: 1488_CR24
  publication-title: Biochim Biophys Acta
  doi: 10.1016/S0925-4439(97)00028-8
– volume: 13
  start-page: 429
  issue: 4
  year: 2004
  ident: 1488_CR20
  publication-title: Hum Mol Genet
  doi: 10.1093/hmg/ddh046
– volume: 13
  start-page: S33
  year: 1998
  ident: 1488_CR23
  publication-title: J Gastroenterol Hepatol
  doi: 10.1111/jgh.1998.13.s1.33
– volume: 10
  start-page: 20
  issue: 1
  year: 1990
  ident: 1488_CR26
  publication-title: Semin Liver Dis
  doi: 10.1055/s-2008-1040454
– volume: 300
  start-page: G709
  issue: 5
  year: 2011
  ident: 1488_CR16
  publication-title: Am J Physiol Gastrointest Liver Physiol
  doi: 10.1152/ajpgi.00451.2010
– volume: 64
  start-page: 830
  issue: 5
  year: 2015
  ident: 1488_CR14
  publication-title: Gut
  doi: 10.1136/gutjnl-2014-306842
– volume: 88
  start-page: 125
  issue: 1
  year: 2008
  ident: 1488_CR5
  publication-title: Physiol Rev
  doi: 10.1152/physrev.00013.2007
– volume: 4
  issue: 3
  year: 2002
  ident: 1488_CR8
  publication-title: Med Gen Med
– volume: 18
  start-page: 449
  issue: 11
  year: 2014
  ident: 1488_CR29
  publication-title: BMC Complement Altern Med
  doi: 10.1186/1472-6882-14-449
– volume: 115
  start-page: 209
  issue: 2
  year: 2005
  ident: 1488_CR2
  publication-title: J Clin Invest
  doi: 10.1172/JCI24282
– volume: 13
  start-page: 19
  issue: 1
  year: 2002
  ident: 1488_CR21
  publication-title: Cell Growth Differ
– volume: 36
  start-page: 131
  issue: 3
  year: 2003
  ident: 1488_CR32
  publication-title: Cell Prolif
  doi: 10.1046/j.1365-2184.2003.00266.x
– volume: 56
  start-page: 1171
  issue: 5
  year: 2012
  ident: 1488_CR9
  publication-title: J Hepatol
  doi: 10.1016/j.jhep.2011.09.024
– volume: 134
  start-page: 1655
  issue: 6
  year: 2008
  ident: 1488_CR4
  publication-title: Gastroenterology
  doi: 10.1053/j.gastro.2008.03.003
– volume: 102
  start-page: 538
  issue: 3
  year: 1998
  ident: 1488_CR25
  publication-title: Clin Invest
  doi: 10.1172/JCI1018
– volume: 11
  start-page: 224
  issue: 3
  year: 2013
  ident: 1488_CR10
  publication-title: Clin Gastroenterol Hepatol
  doi: 10.1016/j.cgh.2013.01.005
– volume: 465
  start-page: 281
  issue: 3
  year: 2003
  ident: 1488_CR19
  publication-title: Eur J Pharmacol
  doi: 10.1016/S0014-2999(03)01528-0
– volume: 264
  start-page: 10756
  issue: 18
  year: 1989
  ident: 1488_CR28
  publication-title: J Biol Chem
  doi: 10.1016/S0021-9258(18)81686-6
– volume: 25
  issue: 3
  year: 2009
  ident: 1488_CR7
  publication-title: Curr Opin Gastroenterol
– volume: 67
  start-page: 246
  issue: 3
  year: 2013
  ident: 1488_CR34
  publication-title: Biomed Pharmacother
  doi: 10.1016/j.biopha.2012.10.002
– volume: 14
  start-page: 780
  issue: 10
  year: 2006
  ident: 1488_CR22
  publication-title: Zhonghua Gan Zang Bing Za Zhi (Chinese)
– volume: 12
  start-page: 939
  issue: 4
  year: 2008
  ident: 1488_CR11
  publication-title: Clin Liver Dis
  doi: 10.1016/j.cld.2008.07.011
– volume: 138
  start-page: 1177
  issue: 3
  year: 2005
  ident: 1488_CR17
  publication-title: Plant Physiol
  doi: 10.1104/pp.104.900160
– volume: 27
  start-page: 402
  issue: 4
  year: 2011
  ident: 1488_CR12
  publication-title: Zhongguo Ying Yong Sheng Li Xue Za Zhi (Chinese)
– volume: 38
  start-page: S38
  issue: 1
  year: 2003
  ident: 1488_CR15
  publication-title: J Hepatol
  doi: 10.1016/S0168-8278(02)00429-4
– volume: 56
  start-page: 335
  issue: 5
  year: 1995
  ident: 1488_CR27
  publication-title: Digestion
  doi: 10.1159/000201257
– volume: 51
  start-page: 109
  issue: 2
  year: 1992
  ident: 1488_CR18
  publication-title: Folia Morphol (Warsz)
– volume: 10
  start-page: 238
  year: 2010
  ident: 1488_CR31
  publication-title: BMC Cancer
  doi: 10.1186/1471-2407-10-238
– volume: 6
  start-page: 1231
  issue: 6
  year: 2012
  ident: 1488_CR13
  publication-title: Mol Med Rep
  doi: 10.3892/mmr.2012.1076
– volume-title: Hepatol Res
  year: 2015
  ident: 1488_CR30
– volume: 682
  start-page: 3
  year: 2011
  ident: 1488_CR33
  publication-title: Methods Mol Biol
  doi: 10.1007/978-1-60327-409-8_1
– volume: 25
  start-page: 195
  issue: 2
  year: 2011
  ident: 1488_CR6
  publication-title: Best Pract Res Clin Gastroenterol
  doi: 10.1016/j.bpg.2011.02.005
– volume: 193
  start-page: 225
  issue: 3
  year: 2011
  ident: 1488_CR1
  publication-title: Chem Biol Interaction
  doi: 10.1016/j.cbi.2011.07.001
– volume: 89
  start-page: 289
  issue: 3
  year: 2015
  ident: 1488_CR35
  publication-title: Arch Toxicol
  doi: 10.1007/s00204-014-1448-7
– reference: 16009993 - Plant Physiol. 2005 Jul;138(3):1177-84
– reference: 14709595 - Hum Mol Genet. 2004 Feb 15;13(4):429-36
– reference: 9691091 - J Clin Invest. 1998 Aug 1;102(3):538-49
– reference: 11897564 - Front Biosci. 2002 Apr 01;7:d808-26
– reference: 12814430 - Cell Prolif. 2003 Jun;36(3):131-49
– reference: 21497738 - Best Pract Res Clin Gastroenterol. 2011 Apr;25(2):195-206
– reference: 23201010 - Biomed Pharmacother. 2013 Apr;67(3):246-50
– reference: 11801528 - Cell Growth Differ. 2002 Jan;13(1):19-26
– reference: 12681440 - Eur J Pharmacol. 2003 Apr 4;465(3):281-7
– reference: 23305825 - Clin Gastroenterol Hepatol. 2013 Mar;11(3):224-31.e1-5
– reference: 2186486 - Semin Liver Dis. 1990 Feb;10(1):20-9
– reference: 18984475 - Clin Liver Dis. 2008 Nov;12(4):939-62, xi
– reference: 25681399 - Gut. 2015 May;64(5):830-41
– reference: 2732246 - J Biol Chem. 1989 Jun 25;264(18):10756-62
– reference: 18471545 - Gastroenterology. 2008 May;134(6):1655-69
– reference: 28976699 - J Gastroenterol Hepatol. 1998 Sep;13(S1):S33-S38
– reference: 22245903 - J Hepatol. 2012 May;56(5):1171-80
– reference: 25407538 - BMC Complement Altern Med. 2014 Nov 18;14 :449
– reference: 21803030 - Chem Biol Interact. 2011 Sep 30;193(3):225-31
– reference: 25753357 - Hepatol Res. 2016 Mar;46(3):E15-25
– reference: 22295510 - Zhongguo Ying Yong Sheng Li Xue Za Zhi. 2011 Nov;27(4):402-6
– reference: 8549875 - Digestion. 1995;56(5):335-46
– reference: 15690074 - J Clin Invest. 2005 Feb;115(2):209-18
– reference: 17064479 - Zhonghua Gan Zang Bing Za Zhi. 2006 Oct;14(10):780-2
– reference: 25618543 - Arch Toxicol. 2015 Mar;89(3):289-317
– reference: 21233278 - Am J Physiol Gastrointest Liver Physiol. 2011 May;300(5):G709-15
– reference: 21057916 - Methods Mol Biol. 2011;682:3-13
– reference: 9300799 - Biochim Biophys Acta. 1997 Aug 22;1361(2):177-84
– reference: 22971838 - Mol Med Rep. 2012 Dec;6(6):1231-8
– reference: 20504360 - BMC Cancer. 2010 May 26;10 :238
– reference: 12591185 - J Hepatol. 2003;38 Suppl 1:S38-53
– reference: 1478568 - Folia Morphol (Warsz). 1992;51(2):109-18
– reference: 18195085 - Physiol Rev. 2008 Jan;88(1):125-72
SSID ssj0057624
Score 1.6667829
Snippet Liver fibrosis is an important health problem that can further progress into cirrhosis or liver cancer,and result in significant morbidity and mortality....
Summary Liver fibrosis is an important health problem that can further progress into cirrhosis or liver cancer, and result in significant morbidity and...
Liver fibrosis is an important health problem that can further progress into cirrhosis or liver cancer, and result in significant morbidity and mortality....
SourceID wanfang
pubmed
crossref
springer
chongqing
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 672
SubjectTerms Animals
Apoptosis - drug effects
bcl-2-Associated X Protein - agonists
bcl-2-Associated X Protein - genetics
bcl-2-Associated X Protein - metabolism
Bcl-2/Bax
Cell Line, Transformed
Cell Proliferation - drug effects
Dose-Response Relationship, Drug
G1 Phase Cell Cycle Checkpoints - drug effects
G1 Phase Cell Cycle Checkpoints - genetics
Gene Expression Regulation
Growth Inhibitors - pharmacology
Hepatic Stellate Cells - cytology
Hepatic Stellate Cells - drug effects
Hepatic Stellate Cells - metabolism
Kinetin - pharmacology
Medicine
Medicine & Public Health
Proto-Oncogene Proteins c-bcl-2 - antagonists & inhibitors
Proto-Oncogene Proteins c-bcl-2 - genetics
Proto-Oncogene Proteins c-bcl-2 - metabolism
Rats
Signal Transduction
比值
激动素
细胞凋亡
细胞周期
细胞增殖
肝纤维化
诱导凋亡
Title Kinetin Inhibits Proliferation of Hepatic Stellate Cells by Interrupting Cell Cycle and Induces Apoptosis by Down-regulating Ratio of Bcl-2/Bax
URI http://lib.cqvip.com/qk/85740A/201505/666317658.html
https://link.springer.com/article/10.1007/s11596-015-1488-0
https://www.ncbi.nlm.nih.gov/pubmed/26489620
https://d.wanfangdata.com.cn/periodical/tjykdxxb-e201505010
Volume 35
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
journalDatabaseRights – providerCode: PRVAVX
  databaseName: SpringerLINK - Czech Republic Consortium
  customDbUrl:
  eissn: 1993-1352
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0057624
  issn: 1672-0733
  databaseCode: AGYKE
  dateStart: 19970101
  isFulltext: true
  titleUrlDefault: http://link.springer.com
  providerName: Springer Nature
– providerCode: PRVAVX
  databaseName: SpringerLink Journals (ICM)
  customDbUrl:
  eissn: 1993-1352
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0057624
  issn: 1672-0733
  databaseCode: U2A
  dateStart: 20020101
  isFulltext: true
  titleUrlDefault: http://www.springerlink.com/journals/
  providerName: Springer Nature
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1Lb9QwELZgKyEuUN5LaeVDTyCXvOwmxy1qqajKqSuVU-RXdtNWTthkxS5_gr_MTF5bKlSpp0jxeJxoJvY3mRch-4ZzbnylmMLcj8gkMZNeYlgcyUPj2SizTZGk8-_idBp9u-SXXR531Ue79y7JZqfeJLvByYvWL2cA4WMGdvoWR_tkRLYmX3-cHfcbMCDotpetOMTAyjDsnZn_Y4IlFeaFm_2EBf85mobzaHCQNmk9LpNudusEOnlOLvpnbwNPrg-WtTrQv--UdXzgy22TZx0ipZNWhV6QR9a9JE_OO5_7K_LnDC517mju5rnK64qW2Okns63u0CKjc4tx2ZpWmJIC4JWiO6Ciak2xGsVisSwxuLq5S_UaVqHSGRgzoFcVlWVR1kWVNxNM8cuxhZ01XcVgTrMIrnGkb1jw-UiuXpPpyfHFl1PWtXFgGqzFmmnP-DbmnhUa_b4y8I1WUtjYk9qLo4irJFaJFp4KQ24Ar8aJnykeGbDklNYmfENGrnD2HaFApSMrfIHIw4SxDJXMEtiHLNi5Uogx2RmkmZZtuY4UDDQASYC0xsTr5ZvqrgI6NuK4STe1m1EMKYghRTGk3ph8HKb0_O4hftsqzUCK4YOJCGDkUy_2tNsjqvv47HeKtiGur9bXZrVSqQ3wHxUHM_r9g5jukKdBo14Yh_iBjOrF0u4CnqrVXvf97JHH02DyFyO0Ft0
linkProvider Springer Nature
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1Lb9QwELbQVgIuvClLefjQE8glD9t1ji1qWdhuT1upnCy_shtaJWGTFbv8Cf4y4zx2AaFKPUWKx-NEM7G_ybwQ2reMMRtqTbTP_aA2EUQFiSWCqkMbOJq6pkjS5JyPLuiXS3bZ5XFXfbR775JsduptshucvN76ZQQgvCBgp-_QUAg6QDtHn76OT_oNGBB028uWH_rAyjjunZn_Y-JLKsyLfPYdFvzraNqcRxsHaZPWk6cqn_1xAp0-RNP-2dvAk6uDZa0PzM9_yjre8uUeoQcdIsVHrQo9Rndc_gTdnXQ-96fo1xgudZbjLJ9nOqsrXPpOP6lrdQcXKZ47H5dtcOVTUgC8Yu8OqLBeY1-NYrFYlj64urmLzRpWwSq3MGZBryqsyqKsiyprJtjiR04WbtZ0FYM5zSJ-jWNzTaIPx2r1DF2cnkw_jkjXxoEYsBZrYgIbOsECx433-6ootEYr7kSgTCAoZToROjE80HHMLOBVkYSpZtSCJaeNsfFzNMiL3L1AGKgMdTzkHnnYWKhYqzSBfciBnas4H6K9jTRl2ZbrkGCgAUgCpDVEQS9faboK6L4Rx7Xc1m72YpAgBunFIIMhereZ0vO7gXi3VZoNqQ8fTHgEI-97sctuj6hu4rPfKdqWuP62vrKrlZYu8v-oGJjRL2_F9C26N5pOzuTZ5_PxHrofNarmYxJfoUG9WLrXgK1q_ab7ln4D3DUY5Q
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1Jb9QwFLZQkSouiJ2hLD70BLImi-0mxxYYFUorDozUm-UtnUDlhEkqzfwK_jLvZRuQUCVOkeJNynP8vs9vI-TQCSFcbAwzGPvBXZ4xHeWOZVwfucjzwndJks4v5OmSf74Ul0Od02b0dh9Nkn1MA2ZpCu28dsV8F_gGWhiZsGAA5zMGnP0uB1WN7GuZHI9HMWDpvqqtPEIXyzQdzZr_mgKTK6yqcPUTlv5LSU2aaTKVdgE-odDh6g9dtHhA7g8gkh73Un9I7vjwiOyfD2byx-TXGTzaMtAyrEpTtg2tsThP4Xtx06qgK4-u1JY2GEUCeJPiDX5DzZZiAon1-qZGf-juLbVbWIXq4KDNwVZoqK6ruq2ashvggMizdV_THsd0i-AaJ_aaJfMTvXlClouP396fsqHyArNA8FpmIxf7TEReWjTV6iR21mjps0jbKONcmDwzuZWRSVPhAGJmeVwYwR2QL2OtS5-SvVAF_5xQ6GW5l7FEsODSTKdGFzkcHR6oqZZyRg6mz67qPsOGAk4FuAbA0YxEoyCUHZKWY-2Ma7VLt4xyVCBHhXJU0Yy8nYaM893S-Vkv3akrevzlMoGWd6O41fBbN7fNczjsiF3n9vv2h9tsjPIJXisJYL4v_mvSN2T_64eF-vLp4uyA3Eu6rYpehC_JXru-8a8ADbXmdbfjfwMCVwBZ
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Kinetin+inhibits+proliferation+of+hepatic+stellate+cells+by+interrupting+cell+cycle+and+induces+apoptosis+by+down-regulating+ratio+of+Bcl-2%2FBax&rft.jtitle=Journal+of+Huazhong+University+of+Science+and+Technology.+Medical+sciences&rft.au=Zhang%2C+Zhen-Gang&rft.au=Zou%2C+Jie&rft.au=Huang%2C+Ying&rft.au=Wu%2C+Liang&rft.date=2015-10-01&rft.eissn=1993-1352&rft.volume=35&rft.issue=5&rft.spage=672&rft_id=info:doi/10.1007%2Fs11596-015-1488-0&rft_id=info%3Apmid%2F26489620&rft.externalDocID=26489620
thumbnail_s http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=http%3A%2F%2Fimage.cqvip.com%2Fvip1000%2Fqk%2F85740A%2F85740A.jpg
http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=http%3A%2F%2Fwww.wanfangdata.com.cn%2Fimages%2FPeriodicalImages%2Ftjykdxxb-e%2Ftjykdxxb-e.jpg